Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | STK11 |
| Variant | dec exp |
| Impact List | none |
| Protein Effect | no effect |
| Gene Variant Descriptions | STK11 dec exp indicates decreased expression of the Stk11 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified |
| Associated Drug Resistance | |
| Category Variants Paths |
STK11 dec exp |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| STK11 dec exp | lung non-small cell carcinoma | sensitive | Trametinib | Preclinical - Cell line xenograft | Actionable | In a preclinical study, knockdown of STK11 increased sensitivity to Mekinist (trametinib) in non-small cell lung cancer cell lines in culture and in xenograft models (PMID: 27821489). | 27821489 |